Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Robert A. Hauser »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Robert A. Egan < Robert A. Hauser < Robert A. King  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 48.
[0-20] [0 - 20][0 - 48][20-40]
Ident.Authors (with country if any)Title
000895 (2002) Robert A. Hauser [États-Unis] ; Nicholas H G. HolfordQuantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.
000957 (2002) Theresa A. Zesiewicz [États-Unis] ; Sujatha Borra ; Robert A. HauserClozapine withdrawal symptoms in a Parkinson's disease patient.
000D95 (2004) Cheryl H. Waters [États-Unis] ; Kapil D. Sethi ; Robert A. Hauser ; Eric Molho ; John M. BertoniZydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: a 3-month, randomized, placebo-controlled study.
000E96 (2004) Matthew B. Stern [États-Unis] ; Kenneth L. Marek ; Joseph Friedman ; Robert A. Hauser ; Peter A. Lewitt ; Daniel Tarsy ; C Warren OlanowDouble-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients.
001032 (2004) Robert A. Hauser [États-Unis] ; Frieda Deckers ; Philippe LehertParkinson's disease home diary: further validation and implications for clinical trials.
001044 (2004) Theresa A. Zesiewicz [États-Unis] ; Elan D. Louis ; Kelly L. Sullivan ; Martin Menkin ; Peter B. Dunne ; Robert A. HauserSubstantial improvement in a Meige's syndrome patient with levetiracetam treatment.
001177 (2005) Daniel Truong [États-Unis] ; Drake D. Duane ; Joseph Jankovic [États-Unis] ; Carlos Singer ; Lauren C. Seeberger ; Cynthia L. Comella ; Mark F. Lew ; Robert L. Rodnitzky ; Fabio O. Danisi ; James P. Sutton ; P David Charles ; Robert A. Hauser ; Geoffrey L. SheeanEfficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
001192 (2005) Maria V. Recio [États-Unis] ; Robert A. Hauser ; Elan D. Louis ; Harsha Radhashakar ; Kelly L. Sullivan ; Theresa A. ZesiewiczChorea in a patient with cerebral palsy: treatment with levetiracetam.
001198 (2005) Kelly L. Sullivan ; Robert A. Hauser ; Theresa A. ZesiewiczLevetiracetam for the treatment of essential tremor.
001288 (2005) Theresa A. Zesiewicz [États-Unis] ; Kelly L. Sullivan ; John L. Maldonado ; William O. Tatum ; Robert A. HauserOpen-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.
001423 (2006) Kelly L. Sullivan [États-Unis] ; Joseph F. Staffetti ; Robert A. Hauser ; Peter B. Dunne ; Theresa A. ZesiewiczTegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease.
001535 (2006) Theresa A. Zesiewicz ; Kelly L. Sullivan ; Robert A. HauserVascular hemichorea/hemiballismus and topiramate.
001660 (2006) Summer C. Wolfrath [États-Unis] ; Amy R. Borenstein ; Skai Schwartz ; Robert A. Hauser ; Kelly L. Sullivan ; Theresa A. ZesiewiczUse of nutritional supplements in Parkinson's disease patients.
001811 (2006) Theresa A. Zesiewicz [États-Unis] ; Kelly L. Sullivan ; Robert A. Hauser ; Juan Sanchez-RamosOpen-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
001945 (2007) Theresa A. Zesiewicz [États-Unis] ; Christopher L. Ward ; Robert A. Hauser ; Jessica A. Pease Campbell ; Kelly L. SullivanPregabalin (Lyrica) in the treatment of essential tremor.
001989 (2007) Theresa A. Zesiewicz [États-Unis] ; Christopher L. Ward ; Robert A. Hauser ; Juan Sanchez-Ramos ; Joseph F. Staffetti ; Kelly L. SullivanA double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.
001996 (2007) Robert A. Hauser [États-Unis] ; Laurence Salin ; Nolwenn Juhel ; Victor L. KonyagoRandomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease.
001D20 (2007) Theresa A. Zesiewicz [États-Unis] ; Christopher L. Ward ; Robert A. Hauser ; Jason L. Salemi ; Shaila Siraj ; Maria-Carmen Wilson ; Kelly L. SullivanA pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor.
001D84 (2007) Theresa A. Zesiewicz ; Kelly L. Sullivan ; Christopher L. Ward ; Robert A. HauserTiagabine and exacerbation of essential tremor.
001E48 (2007) Robert A. Hauser [États-Unis] ; Olivier Rascol ; Amos D. Korczyn ; A. Jon Stoessl ; Ray L. Watts ; Werner Poewe [Autriche] ; Peter P. De Deyn ; Anthony E. LangTen-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
002037 (2008) Christopher G. Goetz [États-Unis] ; Joanne Wuu ; Michael P. Mcdermott ; Charles H. Adler ; Stanley Fahn ; Curt R. Freed ; Robert A. Hauser ; Warren C. Olanow ; Ira Shoulson ; P K Tandon ; Sue LeurgansPlacebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Robert A. Hauser" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Robert A. Hauser" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Robert A. Hauser
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024